These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9380062)

  • 21. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease.
    Westberg L; Håkansson A; Melke J; Shahabi HN; Nilsson S; Buervenich S; Carmine A; Ahlberg J; Grundell MB; Schulhof B; Klingborg K; Holmberg B; Sydow O; Olson L; Johnels EB; Eriksson E; Nissbrandt H
    Psychoneuroendocrinology; 2004 Sep; 29(8):993-8. PubMed ID: 15219649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders.
    Furlong RA; Ho L; Walsh C; Rubinsztein JS; Jain S; Paykel ES; Easton DF; Rubinsztein DC
    Am J Med Genet; 1998 Feb; 81(1):58-63. PubMed ID: 9514589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [VNTR polymorphisms of the serotonin transporter and dopamine transporter genes in male opiate addicts].
    Galeeva AR; Gareeva AE; Iur'ev EB; Khusnutdinova EK
    Mol Biol (Mosk); 2002; 36(4):593-8. PubMed ID: 12173460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polymorphism of the dopamine transporter gene in populations of the Volga-Ural region].
    Galeeva AR; Iur'ev EB; Khusnutdinova EK
    Genetika; 2001 Jul; 37(7):1018-20. PubMed ID: 11558224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
    Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
    Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients.
    Lin JJ; Yueh KC; Chang DC; Chang CY; Yeh YH; Lin SZ
    J Neurol Sci; 2003 May; 209(1-2):87-92. PubMed ID: 12686408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
    Van Kampen JM; McGeer EG; Stoessl AJ
    Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphism of the 3' VNTR region of the human dopaminergic function gene DAT1 (human dopamine transporter gene) in the Mongolian population.
    Nakatome M; Honda K; Tun Z; Kato Y; Harihara S; Omoto K; Misawa S; Gerelsaikhan T; Nyamkhishig S; Dashnyam B; Batsuuri J; Wakasugi C
    Hum Biol; 1996 Aug; 68(4):509-15. PubMed ID: 8754257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cloned dopamine transporter. Potential insights into Parkinson's disease pathogenesis.
    Uhl GR; Kitayama S
    Adv Neurol; 1993; 60():321-4. PubMed ID: 8380524
    [No Abstract]   [Full Text] [Related]  

  • 32. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia.
    Kaiser R; Tremblay PB; Schmider J; Henneken M; Dettling M; Müller-Oerlinghausen B; Uebelhack R; Roots I; Brockmöller J
    Mol Psychiatry; 2001 Mar; 6(2):179-85. PubMed ID: 11317220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PITX3 polymorphism is associated with early onset Parkinson's disease.
    Bergman O; Håkansson A; Westberg L; Nordenström K; Carmine Belin A; Sydow O; Olson L; Holmberg B; Eriksson E; Nissbrandt H
    Neurobiol Aging; 2010 Jan; 31(1):114-7. PubMed ID: 18420308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The serotonin transporter gene and Parkinson's disease.
    McCann SJ; McManus ME; Johnson AG; Mellick GD; Le Couteur DG; Pond SM
    Eur Neurol; 2000; 44(2):108-11. PubMed ID: 10965163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association study for Parkinson's disease and a dopamine transporter gene polymorphism (1215A/G).
    Lin CN; Liu HC; Tsai SJ; Liu TY; Hong CJ
    Eur Neurol; 2002; 48(4):207-9. PubMed ID: 12422069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease.
    Wang J; Zhao C; Chen B; Liu ZL
    Neurosci Lett; 2004 Jan; 355(3):193-6. PubMed ID: 14732464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found.
    Mercier G; Turpin JC; Lucotte G
    J Neurol; 1999 Jan; 246(1):45-7. PubMed ID: 9987713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease.
    Kelada SN; Costa-Mallen P; Checkoway H; Carlson CS; Weller TS; Swanson PD; Franklin GM; Longstreth WT; Afsharinejad Z; Costa LG
    Pharmacogenet Genomics; 2005 Sep; 15(9):659-68. PubMed ID: 16041244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease.
    Higuchi S; Muramatsu T; Arai H; Hayashida M; Sasaki H; Trojanowski JQ
    J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):107-13. PubMed ID: 9620058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
    Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
    Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.